Mulberroside A
CAS: 102841-42-9
Ref. TM-T6S1597
1mg | 49.00 € | ||
5mg | 89.00 € | ||
10mg | 142.00 € | ||
25mg | 250.00 € | ||
50mg | 417.00 € | ||
100mg | 600.00 € | ||
1ml*10 (DMSO) | 112.00 € |
Product Information
- 2,5′-Dihydroxy-4,3′-bis(β-<span class="text-smallcaps">D</span>-glucopyranosyloxy)-trans-stilbene
- 3-[(1E)-2-[4-(β-<span class="text-smallcaps">D</smallcap>-Glucopyranosyloxy)-2-hydroxyphenyl]ethenyl]-5-hydroxyphenyl β-<smallcap>D</span>-glucopyranoside
- 3-{(E)-2-[4-(beta-D-glucopyranosyloxy)-2-hydroxyphenyl]ethenyl}-5-hydroxyphenyl beta-D-glucopyranoside
- β-<span class="text-smallcaps">D</smallcap>-Glucopyranoside, 3-[(1E)-2-[4-(β-<smallcap>D</span>-glucopyranosyloxy)-2-hydroxyphenyl]ethenyl]-5-hydroxyphenyl
- β-<span class="text-smallcaps">D</smallcap>-Glucopyranoside, 3-[2-[4-(β-<smallcap>D</span>-glucopyranosyloxy)-2-hydroxyphenyl]ethenyl]-5-hydroxyphenyl, (E)-
1. Mulberroside has nephroprotective, hypoglycemic, and antidiabetic effects. 2. Mulberroside A is a glycosylated stilbene of oxyresveratrol; thus, the deglycosylation of Mulberroside A resulted in enhanced inhibition of melanogenesis. 3. Mulberroside A has anti-inflammatory antiapoptotic effects. by decreasing the expressions of tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, and IL-6 and inhibiting the activation of NALP3, caspase-1, and nuclear factor-κB and the phosphorylation of extracellular signal-regulated protein kinases, the c-Jun N-terminal kinase, and p38.
Chemical properties
Technical inquiry about: TM-T6S1597 Mulberroside A
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.